We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Nucleic Acid Extracted from Clinical, Research, and Environmental Samples

By LabMedica International staff writers
Posted on 04 Jul 2012
A rapidly growing biotechnology company has introduced a new kit for extracting nucleic acids from clinical, research, and environmental samples. More...


The new E-Sphere Simple NA Kit was developed by Phthisis Diagnostics (Charlottesville, VA, USA). The E-Sphere Simple NA Kit is the first total nucleic acid extraction product in Phthisis Diagnostics’ Simply Molecular product line.

It develops enzyme-based extraction kits for rapid sample preparation prior to polymerase chain reaction (PCR) applications in laboratories. The kit’s optimized workflow minimizes procedural steps, sample transfers, and potential for error.

The novel E-Sphere method allows manual DNA/RNA extraction from 12 samples in less than 30 minutes total time–from sample to PCR. This streamlined process includes only 4 steps and minimizes contamination risk with only 1 to 2 sample transfers. Samples can be quickly processed within a biological safety cabinet.

Advanced technology in the kit includes the high performance E-Sphere enzyme, a thermostable reagent that digests the sample at 75 °C during 15-minute incubation. A further innovation is the proprietary E-Sphere Clean-up Column, which purifies the DNA/RNA for downstream analysis.

Laboratories have expressed their need for a faster, simpler method to purify DNA/RNA from difficult sample types prior to PCR amplification and analysis. This new kit answers the market need for speed among manual extraction methods and provides the added benefits of accuracy, improved cost effectiveness, reduced risk of sample contamination, and greater safety for lab technicians. The process requires only standard clinical laboratory equipment.

The new product is part of the developing Simply Molecular product catalog, a range of molecular diagnostic products designed for speed, accuracy, and ease of use that offer solutions for nucleic acid extraction, molecular diagnostics, and laboratory quality control.

Upcoming products will include molecular diagnostics for parasites and fungi, as well as molecular standards for improved laboratory quality control. Phthisis Diagnostics is also developing molecular diagnostic assays using polymerase chain reaction (PCR) technology to detect infectious diseases, including Cryptosporidium, Giardia, Microsporidia, and others.

Related Links:
Phthisis Diagnostics



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Electrolyte Analyzer
BKE-B
New
Slide Scanner System
NanoZoomer S540MD
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: iStock

Prehospital Blood Test Could Reduce Emergency Transfers for Chest Pain

Chest pain leads to ambulance transport to an emergency department for about 95% of patients, although only a minority have a serious cardiac condition. Troponin testing helps assess heart muscle damage,... Read more

Immunology

view channel
Image: Aptiva utilizes particle-based multi-analyte technology (PMAT) (Photo courtesy of Werfen)

Werfen Expands Automated APS Testing with FDA-Cleared and CE-Marked IgA Reagent

Antiphospholipid syndrome (APS) is an autoimmune disorder associated with thrombosis and pregnancy complications, but its symptoms can overlap with those of other conditions, complicating diagnosis.... Read more

Microbiology

view channel
Image: Each PhAST instrument supports random-access processing of up to four samples simultaneously, delivering a throughput of up to 12 samples per eight-hour shift. (Photo courtesy of PhAST)

FDA Clears Rapid Phenotypic Antimicrobial Susceptibility System for Positive Blood Cultures

Bloodstream infections require prompt treatment, but antimicrobial susceptibility results often lag behind a positive blood culture. Conventional testing can take another 24 to 48 hours after a culture... Read more

Technology

view channel
Image: ADLM recommends that emerging AI tools follow the same professional oversight, quality, validation, and monitoring standards as traditional clinical testing within CLIA’s existing framework (Image Credit: Adobe Stock)

ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine

Clinical laboratories increasingly use artificial intelligence to verify, interpret, and report results, but safeguards under the Clinical Laboratory Improvement Amendments (CLIA) were designed in 1992.... Read more

Industry

view channel
Image

Collaboration Combines AI Cognitive Assessment and RNA Blood Testing for Earlier Alzheimer’s Detection

Alzheimer’s disease is often identified only after substantial neurodegeneration, partly because current diagnostic pathways are fragmented and difficult to scale. As treatment shifts toward earlier intervention,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.